SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-032508
Filing Date
2021-02-08
Accepted
2021-02-08 17:20:08
Documents
17
Period of Report
2021-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d92726d8k.htm   iXBRL 8-K 32822
2 EX-1.1 d92726dex11.htm EX-1.1 249995
3 EX-5.1 d92726dex51.htm EX-5.1 7006
4 EX-99.1 d92726dex991.htm EX-99.1 10101
5 EX-99.2 d92726dex992.htm EX-99.2 10542
9 GRAPHIC g92726g0208232037944.jpg GRAPHIC 2729
  Complete submission text file 0001193125-21-032508.txt   514268

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kldo-20210203.xsd EX-101.SCH 3065
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20210203_lab.xml EX-101.LAB 18121
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20210203_pre.xml EX-101.PRE 11401
10 EXTRACTED XBRL INSTANCE DOCUMENT d92726d8k_htm.xml XML 3341
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 21602532
SIC: 2836 Biological Products, (No Diagnostic Substances)